Insights

Strong Industry Position XenoTech has established itself as a trusted provider in the drug metabolism and DDI research space, serving 98% of top pharmaceutical companies and a broad range of biotech and research institutions. This extensive client base indicates significant opportunities for expanding service offerings and cross-selling advanced pharmacokinetic solutions.

Recent Growth Initiatives The company’s recent acquisition of Cytesbiotech and the appointment of a new CEO reflect strategic growth and leadership focus on enhancing biospecimen solutions and research capabilities. These developments suggest a momentum that can be leveraged to introduce new testing services and customized research collaborations.

Innovation & Product Launches BioIVT’s launch of LEUKOMAX XL and participation in prominent industry events signal ongoing innovation and a proactive approach to expanding its cellular and biospecimen product portfolio. Sales efforts can target research organizations seeking high-quality, large-volume cell and tissue resources for advanced drug development projects.

Global Collaboration & Partnerships Strategic partnerships with companies like IDBS and Krishgen Biosystems demonstrate BioIVT’s commitment to integrating advanced systems and expanding regional reach. This network creates opportunities to promote integrated research solutions, data management tools, and broader biospecimen access across diverse markets.

Financial Confidence With revenues between $25M and $50M and ongoing strategic investments, XenoTech is positioned for sustainable growth. This financial stability can be emphasized to prospective clients and partners seeking reliable and scalable research services for their early-stage drug safety and development programs.

Similar companies to XenoTech, A BioIVT Company

XenoTech, A BioIVT Company Tech Stack

XenoTech, A BioIVT Company uses 8 technology products and services including Google Fonts API, ADP, Element UI, and more. Explore XenoTech, A BioIVT Company's tech stack below.

  • Google Fonts API
    Font Scripts
  • ADP
    Human Resource Management System
  • Element UI
    Javascript Frameworks
  • Swiper
    Javascript Libraries
  • Qualtrics
    Online Form Builders
  • Google Tag Manager
    Tag Management
  • Nginx
    Web Servers
  • Twitter
    Widgets

Media & News

XenoTech, A BioIVT Company's Email Address Formats

XenoTech, A BioIVT Company uses at least 3 format(s):
XenoTech, A BioIVT Company Email FormatsExamplePercentage
FLast@xenotechllc.comJDoe@xenotechllc.com
91%
First.Last@xenotechllc.comJohn.Doe@xenotechllc.com
9%
FLast@xenotech.comJDoe@xenotech.com
78%
First-Last@xenotech.comJohn-Doe@xenotech.com
14%
L.First@xenotech.comD.John@xenotech.com
5%
LastFir@xenotech.comDoeJoh@xenotech.com
1%
Last.First@xenotech.comDoe.John@xenotech.com
2%
FLast@bioivt.comJDoe@bioivt.com
99%
First_Last@bioivt.comJohn_Doe@bioivt.com
1%

Frequently Asked Questions

Where is XenoTech, A BioIVT Company's headquarters located?

Minus sign iconPlus sign icon
XenoTech, A BioIVT Company's main headquarters is located at 1101 West Cambridge Circle Drive Kansas City, Kansas 66103 United States. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is XenoTech, A BioIVT Company's phone number?

Minus sign iconPlus sign icon
You can contact XenoTech, A BioIVT Company's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is XenoTech, A BioIVT Company's official website and social media links?

Minus sign iconPlus sign icon
XenoTech, A BioIVT Company's official website is bioivt.com and has social profiles on LinkedIn.

What is XenoTech, A BioIVT Company's NAICS code?

Minus sign iconPlus sign icon
XenoTech, A BioIVT Company's NAICS code is 5417 - Scientific Research and Development Services.

How many employees does XenoTech, A BioIVT Company have currently?

Minus sign iconPlus sign icon
As of February 2026, XenoTech, A BioIVT Company has approximately 91 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Finance Officer: H. M.Chief Pitmaster: J. M.Chief Pitmaster: J. M.. Explore XenoTech, A BioIVT Company's employee directory with LeadIQ.

What industry does XenoTech, A BioIVT Company belong to?

Minus sign iconPlus sign icon
XenoTech, A BioIVT Company operates in the Research Services industry.

What technology does XenoTech, A BioIVT Company use?

Minus sign iconPlus sign icon
XenoTech, A BioIVT Company's tech stack includes Google Fonts APIADPElement UISwiperQualtricsGoogle Tag ManagerNginxTwitter.

What is XenoTech, A BioIVT Company's email format?

Minus sign iconPlus sign icon
XenoTech, A BioIVT Company's email format typically follows the pattern of FLast@xenotechllc.com. Find more XenoTech, A BioIVT Company email formats with LeadIQ.

When was XenoTech, A BioIVT Company founded?

Minus sign iconPlus sign icon
XenoTech, A BioIVT Company was founded in 1994.

XenoTech, A BioIVT Company

Research ServicesKansas, United States51-200 Employees

XenoTech is a contract research organization (CRO) specializing in nonclinical drug metabolism & drug-drug interaction (DDI) studies that is part of the BioIVT family. 

Over 25 years, we have grown to serve 98% of the top pharmas plus medium, small and virtual pharma, biotechs, research institutions & universities, and more by assisting them with pharmacokinetics-related safety studies for the drug candidates they are developing, usually before clinical trials. Our leadership and expertise is trusted by industry professionals and academics alike to provide not only superior services and products, but also industry-leading research and new techniques. 

There’s a lot of nuance to understanding pharmacokinetic properties of drug candidates. How they enter/exit specific cells, how long they stay, how they get metabolized by enzymes and what metabolites result—all these properties make up the research area called ADME (Absorption, Distribution, Metabolism and Excretion). ADME represents a key area of preclinical investigation to determine whether a drug is going to be dangerous to someone and to make sure it’s in the correct dose and form to produce the therapeutic effect it’s meant to. In vitro and in vivo studies planned with a consultative approach and tailored study design are key to achieving useful, reliable ADME data.

DDIs are a preventable cause of adverse drug reactions which kill or hurt 350,000 hospitalized patients per year. DDI potential can be evaluated using in vitro data and is encouraged by regulatory authorities to be appropriately investigated early in a drug’s development. Our clients come to us because we are global experts in predicting potential DDI issues in the lab before they could happen in a clinical trial volunteer. Doing these studies earlier and with a trusted expert not only instills confidence in your data, but saves money and reduces your risk of late-stage failure.

Learn more about who we are & how we help at https://bioivt.com/

Section iconCompany Overview

Headquarters
1101 West Cambridge Circle Drive Kansas City, Kansas 66103 United States
Phone number
Website
bioivt.com
NAICS Code
5417 - Scientific Research and Development Services
Founded
1994
Employees
51-200

Section iconFunding & Financials

  • $25M$50M

    XenoTech, A BioIVT Company's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $25M$50M

    XenoTech, A BioIVT Company's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.